Clinical Trial Update: Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial [Phase 2, Phase 3]

View source ↗

Summary

A biomarker-enriched Phase 2/3 trial is evaluating aspirin and lansoprazole for preventing preterm birth in high-risk pregnant women; the study status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Aspirin (Aspirin)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Stanford University | Conditions: Pre-term Birth | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING